Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment Article

Sperduto, Paul W, Marqueen, Kathryn E, Chang, Enoch et al. (2025). Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment . JOURNAL OF CLINICAL ONCOLOGY, 43(16), 10.1200/JCO-24-01351

International Collaboration

cited authors

  • Sperduto, Paul W; Marqueen, Kathryn E; Chang, Enoch; Li, Jing; Davies, Michael A; Ebner, Daniel K; Breen, William G; Lamba, Nayan; Shih, Helen A; Edwards, Donna; Kim, Michelle M; Mahal, Amandeep; Rahman, Rifaquat; Ankrah, Nii; Boggs, Drexell H; Lewis, Calvin; Hyer, Daniel; Buatti, John M; Johri, Fasila; Soliman, Hany; Masucci, Laura; Roberge, David; Aneja, Sanjay; Chiang, Veronica; Phuong, Christina; Braunstein, Steve; Dajani, Salah; Sachdev, Sean; Wan, Zihan; Niedzwiecki, Donna; Vaios, Eugene; Kirkpatrick, John P; Pasetsky, Jared; Wang, Tony JC; Kutuk, Tugce; Kotecha, Rupesh; Ross, Richard B; Rusthoven, Chad G; Nakano, Toshimichi; Tawbi, Hussein A; Mehta, Minesh P

sustainable development goals

authors

publication date

  • June 1, 2025

published in

keywords

  • CANCER
  • COMBINED NIVOLUMAB
  • DABRAFENIB PLUS TRAMETINIB
  • DIAGNOSIS
  • IPILIMUMAB
  • Life Sciences & Biomedicine
  • MULTICENTER
  • MUTANT MELANOMA
  • OPEN-LABEL
  • OUTCOMES
  • Oncology
  • Science & Technology
  • VEMURAFENIB

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 43

issue

  • 16